Correcting for Missing Data When Evaluating Surrogate Markers in a Clinical Trial
Sarah C. Lotspeich, P.D. Anh. Nguyen, Layla Parast · 2026
Read Correcting for Missing Data When Evaluating Surrogate Markers in a Clinical Trial by Sarah C. Lotspeich, P.D. Anh. Nguyen, Layla Parast (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2603-20853.txt.
Description
Lotspeich and co-authors tackle missing data in the validation of surrogate markers in clinical trials. Surrogate markers give early signs of a long term treatment effect. Most checks drop patients with missing data, which can bias results and waste precision. They propose two fixes, one based on inverse probability weighting and one on a semiparametric likelihood method. Tests on simulated data stay unbiased across more missing data patterns. They also apply the methods to a diabetes trial. All methods ship in the MissSurrogate R package.
Catalog record
| CREATOR | Sarah C. Lotspeich, P.D. Anh. Nguyen, Layla Parast |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 65709 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2603.20853